0001626108-14-000001.txt : 20141124 0001626108-14-000001.hdr.sgml : 20141124 20141124093741 ACCESSION NUMBER: 0001626108-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141124 DATE AS OF CHANGE: 20141124 EFFECTIVENESS DATE: 20141124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BeneVir Biopharm, Inc. CENTRAL INDEX KEY: 0001626108 IRS NUMBER: 450674059 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-228907 FILM NUMBER: 141245216 BUSINESS ADDRESS: STREET 1: 9610 MEDICAL CENTER DR STREET 2: STE 200 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 646-594-3703 MAIL ADDRESS: STREET 1: 9610 MEDICAL CENTER DR STREET 2: STE 200 CITY: ROCKVILLE STATE: MD ZIP: 20850 D 1 primary_doc.xml X0707 D LIVE 0001626108 BeneVir Biopharm, Inc. 9610 MEDICAL CENTER DR STE 200 ROCKVILLE MD MARYLAND 20850 646-594-3703 DELAWARE None None Corporation true 2011 Katherine Ann Sacksteder 10301 Grosvenor Place Apt 1709 Rockville MD MARYLAND 20852 Executive Officer Director Matthew Charles Mulvey 10301 Grosvenor Place Apt 1709 Rocvkille MD MARYLAND 20852 Executive Officer Director Biotechnology $1 - $1,000,000 06b false 2014-11-12 true true false 2000000 12000000 2000000 10000000 The offering is contemplated to close in 3 tranches. The first closed on November 12, 2014 and raised $2,000,000. The second would raise $6,000,000, and the third would raise $4,000,000. false 1 0 0 225000 true false BeneVir Biopharm, Inc. Matthew Mulvey Matthew Mulvey CEO 2014-11-24